Loading…
FibroBiologics, Inc. is projected to rise to $1.08 by 2027, a +36% move from its current price of $0.7905. FBLG is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.7548 | $0.7909 | $0.8288 | +0.05% |
| Aug 6 | $0.7407 | $0.7914 | $0.8455 | +0.11% |
| Aug 7 | $0.7302 | $0.7918 | $0.8586 | +0.16% |
| Aug 8 | $0.7215 | $0.7922 | $0.8699 | +0.22% |
| Aug 9 | $0.7139 | $0.7927 | $0.8801 | +0.27% |
| Aug 10 | $0.7072 | $0.7931 | $0.8894 | +0.33% |
| Aug 11 | $0.7011 | $0.7935 | $0.8981 | +0.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7011 | $0.7935 | $0.8981 | +0.38% |
| Week 2 | $0.6686 | $0.7965 | $0.9489 | +0.76% |
| Week 3 | $0.6453 | $0.7996 | $0.9907 | +1.15% |
| Week 4 | $0.6266 | $0.8026 | $1.03 | +1.53% |
| Week 5 | $0.6109 | $0.8057 | $1.06 | +1.92% |
| Week 6 | $0.5972 | $0.8087 | $1.10 | +2.31% |
| Week 7 | $0.5851 | $0.8118 | $1.13 | +2.70% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
FibroBiologics, Inc. is a clinical-stage biotechnology company focused on developing fibroblast-based therapies for chronic diseases. Its product pipeline includes CYWC628, which has completed pre-clinical trial for the treatment of wound healing; CYMS101, which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis.
It also develops early-stage research products, including CYTER915 to treat the human longevity and TCB190 for the treatment of certain cancers. FibroBiologics was incorporated in 2021 and is headquartered in Houston, Texas.
FibroBiologics, Inc. (FBLG) is currently trading around $0.7192 and has a market cap of $3.75M. It is ranked 5065 by market size. The near-term forecast for 2026 shows a min of $0.627, an avg of $0.7192, and a max of $1.08, with an ROI of 0 and a sentiment labeled NEUTRAL.
The longer-term outlook projects upside through the 2027–2035 window and beyond, with 2040 averaging $1.44 (max $3.02; ROI 100.6) and 2050 averaging $2.04 (max $4.68; ROI 183), both sentiment labeled BULLISH. Key intermediate years show a mix of neutral and bullish readings, including 2027 with avg $0.981 and max $1.42 (ROI 36.4) and 2032–2035 showing continued bullish momentum, with 2032 avg $0.955, 2033 avg $1.10, 2034 avg $1.06, and 2035 avg $1.14.
A major floor 44.7% below — a decisive break under it would weaken the trend.
The nearest floor, 20.7% below — buyers have tended to step in here.
The nearest ceiling, 19.9% above — a clean break opens room to run.
A major ceiling 567.9% above — clearing it would confirm fresh momentum.
Key FBLG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FBLG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6702 | Buy | $0.6943 | Buy |
| MA 10 | $0.7093 | Buy | $0.7163 | Buy |
| MA 20 | $0.7813 | Buy | $0.7628 | Buy |
| MA 50 | $0.8811 | Sell | $1.03 | Sell |
| MA 100 | $1.71 | Sell | $2.02 | Sell |
| MA 200 | $4.06 | Sell | $6.71 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.75 | Neutral |
| Stoch RSI (14) | 69.16 | Neutral |
| CCI (20) | -75.28 | Neutral |
| Williams %R (14) | -67.56 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -16.96 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 32.44 | Neutral |
| TRIX (15) | -0.93 | Sell |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 37.53 | Neutral |
| Momentum (10) | -0.13 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 0.67 | Buy |
| ADX (14) | 27.31 | Sell |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is BEARISH, with an RSI(14) of 40. The 50-day simple moving average sits at $0.8887, while the 200-day simple moving average sits at $4.10. Support is noted at $0.627 and resistance at $0.948.
The 30-day price range spans from a low of $0.5238 to a high of $0.9875, indicating limited near-term upside against the backdrop of the larger trend.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.627 | $0.7905 | $1.16 | 0% | Neutral | |
| $0.8038 | $1.08 | $1.55 | +36% | Bullish | |
| $0.6335 | $0.8947 | $1.37 | +13% | Neutral | |
| $0.6033 | $0.8906 | $1.43 | +13% | Neutral | |
| $0.5879 | $0.9032 | $1.50 | +14% | Neutral | |
| $0.4849 | $0.7729 | $1.33 | -2% | Neutral | |
| $0.6304 | $1.04 | $1.84 | +32% | Bullish | |
| $0.7057 | $1.20 | $2.18 | +52% | Bullish | |
| $0.6574 | $1.16 | $2.14 | +47% | Bullish | |
| $0.6844 | $1.24 | $2.35 | +57% | Bullish | |
| $0.7493 | $1.58 | $3.26 | +100% | Bullish | |
| $0.9985 | $2.22 | $5.10 | +181% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.627 | $0.7905 | $0.9862 | +0.00% |
| September 2026 | $0.7007 | $0.8457 | $1.06 | +6.99% |
| October 2026 | $0.68 | $0.8307 | $1.06 | -1.78% |
| November 2026 | $0.6682 | $0.8244 | $1.07 | -0.75% |
| December 2026 | $0.712 | $0.8864 | $1.16 | +7.52% |
Click any year to see its month-by-month FBLG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, FBLG is projected to trade between $0.627 and $1.16, averaging $0.7905 — a potential gain of 0% from today's $0.7905. Price action looks broadly range-bound.
FibroBiologics, Inc.'s 2027 outlook centres on $1.08, within a $0.8038 to $1.55 range. That is up +36% on the projected 2026 average. That marks a +36% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, FBLG could reach as high as $1.37, with a base case around $0.8947 and support toward $0.6335 — roughly +13% from $0.7905. Price action looks broadly range-bound.
Expect FBLG to range from $0.6033 to $1.43 through 2029. The $0.8906 average target implies a +13% move from current prices. That is 0% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The FBLG price prediction for 2030 points to an average of $0.9032 (low $0.5879, high $1.50) — a potential gain of +14% on today's $0.7905. Price action looks broadly range-bound.
In 2031, FBLG is projected to trade between $0.4849 and $1.33, averaging $0.7729 — a potential decline of -2% from today's $0.7905. That is -14% versus the projected 2030 average. A consolidation phase looks the most probable path here.
FibroBiologics, Inc.'s 2032 outlook centres on $1.04, within a $0.6304 to $1.84 range. That is up +35% on the projected 2031 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2033, FBLG could reach as high as $2.18, with a base case around $1.20 and support toward $0.7057 — roughly +52% from $0.7905. Buyers look set to stay in control over this stretch.
Expect FBLG to range from $0.6574 to $2.14 through 2034. The $1.16 average target implies a +47% move from current prices. That is -4% versus the projected 2033 average. Momentum favours further upside here.
The FBLG price prediction for 2035 points to an average of $1.24 (low $0.6844, high $2.35) — a potential gain of +57% on today's $0.7905. Buyers look set to stay in control over this stretch.
In 2040, FBLG is projected to trade between $0.7493 and $3.26, averaging $1.58 — a potential gain of +100% from today's $0.7905. That is up +27% on the projected 2035 average. Momentum favours further upside here.
FibroBiologics, Inc.'s 2050 outlook centres on $2.22, within a $0.9985 to $5.10 range. That is up +40% on the projected 2040 average. That marks a +181% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in FBLG today (≈ 1,265.022138 FBLG) could be worth
$2,806.91
+$1,806.91 (+181%) by 2050 · US Dollar
Based on the average projected FBLG price of $2.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FBLGwould be worth at today's price.
$1,000 invested in FBLG on Jul 31, 2025 (≈ 78.492937 FBLG) would be worth
$62.05
-$937.95 (-93.8%) today · 0.06× · US Dollar
Based on a FBLG entry price of $12.74 vs. today's $0.7905.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.712 | $1,110.25 | +11.0% |
| 1 month ago | $0.906 | $872.52 | -12.7% |
| 3 months ago | $1.46 | $541.44 | -45.9% |
| 6 months ago | $5.68 | $139.17 | -86.1% |
| 1 year ago | $12.74 | $62.05 | -93.8% |
| All time (2.5y) ago | $582 | $1.36 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FBLG forecast.
Our base-case forecast reaches $1.60 around 2050.
Implied market cap at $1.60: $8.33M
The multi-year forecast envisions a path of upside with several bullish years becoming evident after 2026. In 2027 the avg price is projected at $0.981 with a max of $1.42 and a bullish tone, ROI 36.4. From 2027 through 2035, forecasts show sustained upside with 2032 avg $0.955, 2033 avg $1.10, 2034 avg $1.06, 2035 avg $1.14 and corresponding bullish sentiment in these years.
The model also shows continued positive trajectories in 2040 and 2050, with 2040 avg $1.44 (max $3.02; ROI 100.6) and 2050 avg $2.04 (max $4.68; ROI 183). There are counterpoints in certain years, including 2031 with avg $0.6989 and ROI -2.8, indicating neutral sentiment in that year. Overall, the forecast paints meaningful long-term upside but with periods of muted or negative returns, underscoring that these are estimates, not guarantees.
Tap a question to reveal the answer.
The 2026 forecast shows min $0.627, avg $0.7192, max $1.08, ROI 0, sentiment NEUTRAL.
Forecasts show bullish years in 2027 (avg $0.981, max $1.42; ROI 36.4) and in years 2032–2035, 2040 and 2050, but there are neutral and negative years such as 2031 (avg $0.6989; ROI -2.8). These are estimates, not guarantees.
Yes, the 2027 forecast has an avg of $0.981 and a max of $1.42, with ROI 36.4, indicating potential for surpassing $1 within that year.
For 2040 the min is $0.6677, the avg is $1.44, the max is $3.02, and ROI is 100.6, with sentiment BULLISH.
The forecast includes years with neutral or negative ROI (e.g., 2026 ROI 0 and 2031 ROI -2.8), and the asset currently shows BEARISH sentiment in the near term. These are estimates and not financial advice.
FibroBiologics, Inc. Community Discussion
0Share your FibroBiologics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.